Medical/Pharmaceuticals
Australian Dentists Endorse Smartee's Mandibular Repositioning Technology at Global Symposium in Kunming
Clinicians praise the S8-SGTB appliance for accelerating outcomes, improving patient satisfaction, and offering a non-invasive solution for Class II malocclusions. KUNMING, China, July 11, 2025 /PRNewswire/ -- Smartee Denti-Technology recently welcomed orthodontic experts and partners from Austr...
2025-07-11 17:38
2834
Dräger Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation
Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in patient outcomes, clinical efficiency, cost-effectiveness and critical care training SAN ANTONIO, July 10, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce thatDräger has received...
2025-07-10 21:00
2043
Medical Device Manufacturers Accelerate R&D and Speed to Market via Live Prototyping
BOSTON, July 10, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization (CDMO) for industry-leading, multi-national healthcare companies, global medical device manufacturers, and emerging technology companies, is leaning into live prototyping to help ...
2025-07-10 17:00
2311
DKSH and Bayer Launch Strategic Partnership Across Multiple Markets in Southeast Asia
DKSH has signed a strategic business partnership with life science company Bayer, to provide comprehensive services for a portion of the Bayer Pharmaceuticals business in Singapore, Malaysia, Thailand and the Philippines. SINGAPORE, July 10, 2025 /PRNewswire/ -- DKSH Business Unit Healthcare, ...
2025-07-10 10:00
3208
Medidata and the University of Sydney's NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia
Continuing collaboration will utilize the capabilities of the Medidata Data
Experience, fostering efficiency, fast-tracking research breakthroughs, and
raising the standard of clinical trials
SINGAPORE, July 10, 2025 /PRNewswire/ -- Medidata
2025-07-10 08:00
2276
LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico's Life Sciences Market
NORWALK, Conn., July 9, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce the expansion of its distribution partnership with Clariant, a global leader in the development and manufacturing of specialty c...
2025-07-09 23:00
2130
NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports
NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content advisory: Pre-Market update + Trump announces 50% le...
2025-07-09 20:55
3191
IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel
SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced thatits self-developed an...
2025-07-09 20:18
2183
Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets
WALTHAM, Mass., July 9, 2025 /PRNewswire/ -- Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for age-related diseases, today announced a strategic agreement with Novartis under which Sironax will grant Novartis an exclusive option...
2025-07-09 20:00
2291
Gozellix Receives Permanent HCPCS Code
MELBOURNE, Australia, July 9, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that its next-generation PSMA[1] PET[2] imaging agent, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), has been granted a permanent Hea...
2025-07-09 12:41
3312
Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025
TOKYO, July 9, 2025 /PRNewswire/ -- Visitors to the Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp ...
2025-07-09 11:30
2108
BiomeNrich™ PRO G814 & PRO G952: Globally Recognized Bifidobacterium Solutions Now Targeting Southeast Asia's Wellness Market
SEOUL, South Korea, July 9, 2025 /PRNewswire/ -- As Southeast Asia's health and wellness market rapidly evolves, consumer expectations are shifting toward multifunctional solutions that go beyond basic digestion. Gut health is now understood as the foundation for immune support, skin clarity, men...
2025-07-09 07:00
2748
Technimark Unveils New Brand Identity: "We Make What Makes Life Better"
ASHEBORO, N.C., July 9, 2025 /PRNewswire/ -- Technimark, a world leader in manufacturing for healthcare, consumer packaging, and industrial sectors, today launched a new brand identity to reflect the company's transformation into a global manufacturing leader, known for its reliability and excell...
2025-07-09 00:00
2262
Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted metabolomics partner in the life sciences industry MORRISVILLE, N.C., July 8, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science ...
2025-07-08 21:00
1787
GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD SEXUAL ABUSE SURVIVORS
#HopeNeedsAHome Cypress Minerals and Cepham Inc lead Fundraising Efforts Because Hope Needs A Home - Deadline Looms As Mothers, Aged 11-17, Hope For Sanctuary they can call Home $140,000 USD needed by August 15 to Secure Home for young Mothers MADERA, Calif., July 8, 2025 /PRNewswire/ -- Tw...
2025-07-08 20:00
1554
3D-PRINTED CUSTOM INSOLES: ADVANCING DIABETIC FOOT CARE AT SENGKANG GENERAL HOSPITAL
SINGAPORE, July 8, 2025 /PRNewswire/ -- Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre. Traditional p...
2025-07-08 18:47
2031
Zuellig Pharma Launches "Obesity is a Disease" Seminar as Part of "Reduce Size, Reduce Disease" Campaign
The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare providers. BANGKOK, July 8, 2025 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions provider inAsia, is organizing the "Obesity is a Disea...
2025-07-08 16:29
2618
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the Investigation...
2025-07-08 10:02
3434
Better by MTA Highlights Platinum Members Elevating Global Healthcare Standards
PALM BEACH GARDENS, Fla., July 8, 2025 /PRNewswire/ -- Better by MTA, the leading medical tourism platform, is proud to spotlight its distinguished Platinum Members—organizations that exemplify leadership, excellence, and innovation in the global medical travel industry. These members have played ...
2025-07-08 02:26
1826
Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of intervent...
2025-07-07 21:00
2352
Week's Top Stories
Most Reposted
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
[Picked up by 310 media titles]
2026-01-15 13:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 301 media titles]
2026-01-21 12:39JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
[Picked up by 296 media titles]
2026-01-15 10:00Infobip strengthens leadership to drive growth and innovation
[Picked up by 281 media titles]
2026-01-16 11:00
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 279 media titles]
2026-01-20 15:40
